Technical Analysis for CTE - Cryosite Limited

Grade Last Price % Change Price Change
B 0.950 3.26% 0.030
CTE closed up 3.26 percent on Friday, November 1, 2024, on 10 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Boomer Buy Setup Bullish Swing Setup 3.26%
Narrow Range Bar Range Contraction 3.26%

   Recent Intraday Alerts

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cryosite Limited Description

Cryosite Limited is a biotechnology and biologics logistics company. The Company is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The Company operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment provides cord tissue MSC banking to parents, and specialized contract good manufacturing practice (GMP) manufacturing and associated consultancy services to therapeutic and regenerative medicine companies involved in the development and commercialization of technologies. The Scientific Processing and Logistics segment provides specialized commercial drug distribution. The Company also provides specialized bio-repository, clinical trials logistics, commercial drug distribution, contract cellular therapies manufacturing and associated consultancy services to commercial clients both within Australia and internationally.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Manufacturing Medicine Bank Logistics Banking Biotechnology Life Sciences Clinical Trial Biopharmaceutical Pharmaceutical Industry Consultancy Services Regenerative Medicine Regenerative Stem Cell Stem Cells Manufacturing Practice Mesenchymal Stem Cell

Is CTE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.2167
52 Week Low 0.4802
Average Volume 10,784
200-Day Moving Average 0.756
50-Day Moving Average 0.933
20-Day Moving Average 0.794
10-Day Moving Average 0.838
Average True Range 0.028
RSI (14) 67.21
ADX 32.19
+DI 55.424
-DI 33.011
Chandelier Exit (Long, 3 ATRs) 0.865
Chandelier Exit (Short, 3 ATRs) 0.791
Upper Bollinger Bands 0.944
Lower Bollinger Band 0.645
Percent B (%b) 1.02
BandWidth 37.657
MACD Line 0.008
MACD Signal Line -0.024
MACD Histogram 0.0317
Fundamentals Value
Market Cap 44.52 Million
Num Shares 46.9 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 31.67
Price-to-Sales 1.75
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.950
Resistance 3 (R3) 0.950 0.950 0.950
Resistance 2 (R2) 0.950 0.950 0.950 0.950
Resistance 1 (R1) 0.950 0.950 0.950 0.950 0.950
Pivot Point 0.950 0.950 0.950 0.950 0.950
Support 1 (S1) 0.950 0.950 0.950 0.950 0.950
Support 2 (S2) 0.950 0.950 0.950 0.950
Support 3 (S3) 0.950 0.950 0.950
Support 4 (S4) 0.950